- 優先名称
- Lirametostat
- IUPAC
- N-[(4-methoxy-6-methyl-2-oxo-1H-pyridin-3-yl)methyl]-2-methyl-1-[(1R)-1-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]ethyl]indole-3-carboxamide
- 現地名
- N-[(4-メトキシ-6-メチル-2-オキソ-1,2-ジヒドロピリジン-3-イル)メチル]-2-メチル-1-[(R)-1-[1-(2,2,2-トリフルオロエチル)ピペリジン-4-イル]エチル]-1H-インドール-3-カルボキサミド
- 英語名
- CPI-1205
- 分子式
- C27H33F3N4O3
- 分子量
- 518.57
名称と別名
CPI-12051621862-70-1Lirametostat(R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamideEzh2 inhibitor cpi-1205N-[(4-methoxy-6-methyl-2-oxo-1H-pyridin-3-yl)methyl]-2-methyl-1-[(1R)-1-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]ethyl]indole-3-carboxamide455J2479FY1H-Indole-3-carboxamide, N-((1,2-dihydro-4-methoxy-6-methyl-2-oxo-3-pyridinyl)methyl)-2-methyl-1-((1R)-1-(1-(2,2,2-trifluoroethyl)-4-piperidinyl)ethyl)-1H-Indole-3-carboxamide, N-[(1,2-dihydro-4-methoxy-6-methyl-2-oxo-3-pyridinyl)methyl]-2-methyl-1-[(1R)-1-[1-(2,2,2-trifluoroethyl)-4-piperidinyl]ethyl]-N-[(4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl]-2-methyl-1-[(1R)-1-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]ethyl]-1H-indole-3-carboxamideN-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-((1R)-1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamideN-((4-methoxy-6-methyl-2-oxo-1H-pyridin-3-yl)methyl)-2-methyl-1-((1R)-1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)indole-3-carboxamide